Watch Demo

Forecast: Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins) in Latvia

Latvia Hormones Sales is set to reach $8.96 Million by 2026 from $8.25 Million, is expected to increase 4.3% per year. Since 2017, the market jumped by 6.3% year on year totalising $8,140 Million. Germany, the United Kingdom and Italy respectively ranked numbers 2, 3 and 4 in this ranking.